FDA'S Pharmaceutical Quality Initiatives Implementation of a Modern Risk-Based Approach.
| Publicado en: | Pharmaceutical Technology Vol. 32; no. 5; pp. 54 - 73 |
|---|---|
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
May2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108038167&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108038167 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: May2008 vid: 32 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108038167 2011964488 108038167 ppf: 54 ppct: 19 formats: fmt: @attributes: type: P tig: atl: FDA'S Pharmaceutical Quality Initiatives Implementation of a Modern Risk-Based Approach. aug: sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|